Patent Assignment
Reel/Frame 067321/0427
Assignment of Assignor's Interest
Recorded: 2024-05-06
Pages: 5
Assignor
BRIDGEBIO SERVICES, INC.
Executed: 2023-10-24
Assignee
QED THERAPEUTICS, INC.
1800 OWENS STREET, 12TH FLOOR, SAN FRANCISCO, CALIFORNIA, 94158
Covered Property
(1)
Methods of Treating Skeletal Dysplasias
Application:
63/488,709 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Assignment of Assignor's Interest
May 6, 2024
From: ARANGIO, SUSAN; DAMBKOWSKI, CARL; ROGOFF, DANIELA; MONTEITH, MICHAEL
To: QED THERAPEUTICS, INC.
Reel/Frame 067321/0411 →
Assignment of Assignor's Interest
May 6, 2024
From: HENDERSON, MICHAEL
To: BRIDGEBIO SERVICES, INC.
Reel/Frame 067321/0422 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →